Oden, Baby Girl -.
HRN: 27-95-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/23/2025
10/30/2025
IV
36mg
Q24H
PSNB
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes